Atlas Trials

Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections

Clinical trial NCT04722029 · RECRUITING

Trial details

NCT number
NCT04722029
Sponsor
Nationwide Children's Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adenovirus Infection
Start date
2021-10-01
Primary completion
2026-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.